טוען...

Differences in liver parenchyma are measurable with CT radiomics at initial colon resection in patients that develop hepatic metastases from stage II/III colon cancer

BACKGROUND: Currently, there are no methods to identify patients with an increased risk of liver metastases to guide patient selection for liver-directed therapies. We tried to determine whether quantitative image features (radiomics) of the liver obtained from preoperative staging CT scans at the t...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Ann Surg Oncol
Main Authors:	Creasy, John M., Cunanan, Kristen M., Chakraborty, Jayasree, McAuliffe, John C., Chou, Joanne, Gonen, Mithat, Kingham, Victoria S., Weiser, Martin R., Balachandran, Vinod P., Drebin, Jeffrey A., Kingham, T. Peter, Jarnagin, William R., D’Angelica, Michael I., Do, Richard K.G., Simpson, Amber L.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2020
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7940539/ https://ncbi.nlm.nih.gov/pubmed/32954446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-09134-w
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Differences in liver parenchyma are measurable with CT radiomics at initial colon resection in patients that develop hepatic metastases from stage II/III colon cancer

פריטים דומים